LEUPROLIDE 2WK 14 MG/2.8 ML KT
For 1 unit (EA)
Pharmacies pay
$197.61 filed
1 × $197.606 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20, 2026-05-27, 2026-06-03 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit. No Medicare reference price. Part D: The Part D file flags this drug’s average spending per dosage unit as an outlier, so OpenBill does not use it as a reference price. Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$232.25 estimated
$197.61 + $29.64 (15%) + $5.00 fee per fill = $232.25
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-05-20, 2026-06-03 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
LEUPROLIDE 2WK 14 MG/2.8 ML KT is how the CMS NADAC file names this product. The FDA NDC Directory lists it as leuprolide acetate.
FDA gives its dosage form as kit and its route as subcutaneous.
FDA lists 7 labelers (the companies named on the label) for its NDCs, among them PAI Holdings, LLC dba PAI Pharma, Sandoz Inc and Sun Pharmaceutical Industries, Inc.
FDA lists no Established Pharmacologic Class for it.
The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes); the FDA directory lists 7 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $197.61 for 1 unit (EA) (1 × $197.606 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-05-20 and 2026-06-03. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 4, carried forward from the previous file.
The NADAC of all 8 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-05-20, 2026-05-27, 2026-06-03. The file is new; the price is not.
What NADAC measures · NADAC explanation codes · Carried-forward prices
The 7 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Amneal Pharmaceuticals LLC | 1 | $197.606 per EA filed |
| Eugia US LLC | 1 | $197.606 per EA filed |
| Meitheal Pharmaceuticals Inc | 1 | $197.606 per EA filed |
| PAI Holdings, LLC dba PAI Pharma | 1 | $197.606 per EA filed |
| Sandoz Inc | 1 | $197.606 per EA filed |
| Sun Pharmaceutical Industries, Inc. | 1 | $197.606 per EA filed |
| Zydus Pharmaceuticals USA Inc. | 1 | $197.606 per EA filed |
| Not listed as a package in the FDA directory | 1 | $197.606 per EA filed |
When these prices took effect
- 2026-06-03 · 1 NDC, carried forward from an earlier file · $197.606 per EA filed
- 2026-05-27 · 1 NDC, carried forward from an earlier file · $197.606 per EA filed
- 2026-05-20 · 6 NDCs, all carried forward from an earlier file · $197.606 per EA filed
All 8 NDCs, with labeler and price
- 00121-2106-02 · PAI Holdings, LLC dba PAI Pharma · $197.606 per EA · eff. 2026-05-20 filed carried forward
- 00781-4003-32 · Sandoz Inc · $197.606 per EA · eff. 2026-05-20 filed carried forward
- 47335-0936-40 · Sun Pharmaceutical Industries, Inc. · $197.606 per EA · eff. 2026-05-27 filed carried forward
- 55150-0478-01 · Eugia US LLC · $197.606 per EA · eff. 2026-05-20 filed carried forward
- 70121-2537-06 · Amneal Pharmaceuticals LLC · $197.606 per EA · eff. 2026-05-20 filed carried forward
- 70710-1769-03 · Zydus Pharmaceuticals USA Inc. · $197.606 per EA · eff. 2026-06-03 filed carried forward
- 71288-0569-90 · Meitheal Pharmaceuticals Inc · $197.606 per EA · eff. 2026-05-20 filed carried forward
- 83634-0454-61 · not listed as a package in the FDA directory · $197.606 per EA · eff. 2026-05-20 filed carried forward
Other strengths, forms and brands
3 other products in the NADAC file share the FDA nonproprietary name leuprolide acetate with LEUPROLIDE 2WK 14 MG/2.8 ML KT.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| LEUPROLIDE 2WK 14 MG/2.8 ML KT this page | $197.606 per EA filed | We don’t know yet |
| LUPRON DEPOT 3.75 MG KIT | $1,822.07714 per EA filed | $5,177.84908 per EA filed |
| LUPRON DEPOT 7.5 MG 1 MONTH KT | $2,174.1678 per EA filed | $5,177.84908 per EA filed |
| LUPRON DEPOT 11.25 MG 3MO KIT | $5,437.39667 per EA filed | $5,177.84908 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2026-01-02 and 2026-09-23 (6 dates) · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 unit (EA)? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 1 unit (EA)?
- NADAC prices this product per EA, and the FDA NDC Directory lists 7 of its 8 NDCs (it does not list the other one) as dosage form “KIT” with route “SUBCUTANEOUS”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. NADAC’s EA for it may be the whole kit or one item in it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.